Ryuji Kubota

3.7k total citations
111 papers, 2.8k citations indexed

About

Ryuji Kubota is a scholar working on Immunology, Agronomy and Crop Science and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Ryuji Kubota has authored 111 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Immunology, 46 papers in Agronomy and Crop Science and 40 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Ryuji Kubota's work include T-cell and Retrovirus Studies (74 papers), Animal Disease Management and Epidemiology (46 papers) and Vector-Borne Animal Diseases (40 papers). Ryuji Kubota is often cited by papers focused on T-cell and Retrovirus Studies (74 papers), Animal Disease Management and Epidemiology (46 papers) and Vector-Borne Animal Diseases (40 papers). Ryuji Kubota collaborates with scholars based in Japan, United States and China. Ryuji Kubota's co-authors include Mitsuhiro Osame, Shuji Izumo, Steven Jacobson, Yoshitaka Furukawa, Taketo Kawanishi, Mitsutoshi Tara, Shinji Ijichi, Thomas Leist, Fujio Umehara and Jonathan P. Schneck and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Ryuji Kubota

108 papers receiving 2.8k citations

Peers

Ryuji Kubota
William Wachsman United States
Md. Zahidunnabi Dewan Japan
Scott D. Blystone United States
Emma Terwilliger United States
E L Reinherz United States
Chung‐Yi Hu Taiwan
Lucia Mincheva‐Nilsson Sweden
Robert L. Evans United States
Warren B. Nothnick United States
Hisashi Harada Japan
William Wachsman United States
Ryuji Kubota
Citations per year, relative to Ryuji Kubota Ryuji Kubota (= 1×) peers William Wachsman

Countries citing papers authored by Ryuji Kubota

Since Specialization
Citations

This map shows the geographic impact of Ryuji Kubota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuji Kubota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuji Kubota more than expected).

Fields of papers citing papers by Ryuji Kubota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuji Kubota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuji Kubota. The network helps show where Ryuji Kubota may publish in the future.

Co-authorship network of co-authors of Ryuji Kubota

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuji Kubota. A scholar is included among the top collaborators of Ryuji Kubota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuji Kubota. Ryuji Kubota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hiyoshi, Masateru, Akira Ono, Yosuke Maeda, et al.. (2025). M-Sec promotes the accumulation of intracellular HTLV-1 Gag puncta and the incorporation of Env into viral particles. PLoS Pathogens. 21(1). e1012919–e1012919. 1 indexed citations
2.
Tanaka, Masakazu, Norihiro Takenouchi, Toshio Matsuzaki, et al.. (2024). HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load. International Journal of Molecular Sciences. 25(13). 6858–6858. 2 indexed citations
3.
Nozuma, Satoshi, Eiji Matsuura, Masakazu Tanaka, et al.. (2023). Identification and tracking of HTLV-1–infected T cell clones in virus-associated neurologic disease. JCI Insight. 8(7). 4 indexed citations
4.
Matsuura, Eiji, Satoshi Nozuma, Daisuke Kodama, et al.. (2023). Iliopsoas Muscle Weakness as a Key Diagnostic Marker in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Pathogens. 12(4). 592–592. 1 indexed citations
5.
Matsuura, Eiji, Satoshi Nozuma, Tomonori Nakamura, et al.. (2023). HTLV-1-associated myelopathy/tropical spastic paraplegia with sporadic late-onset nemaline myopathy: a case report. BMC Musculoskeletal Disorders. 24(1). 355–355. 2 indexed citations
6.
Tashiro, Yuichi, Eiji Matsuura, Yasuko Sagara, et al.. (2022). High Prevalence of HTLV-1 Carriers Among the Elderly Population in Kagoshima, a Highly Endemic Area in Japan. AIDS Research and Human Retroviruses. 38(5). 363–369. 3 indexed citations
7.
Kaneko, Shinji, Shin Nagai, Yoshinori Shirai, et al.. (2022). The ridge line of left pulmonary vein isolation from left atrial appendage can subsequently increase the completion rate of the mitral isthmus block line. Journal of Interventional Cardiac Electrophysiology. 66(3). 673–681. 1 indexed citations
8.
Kodama, Daisuke, Masakazu Tanaka, Toshio Matsuzaki, et al.. (2021). Anti-Human T-Cell Leukemia Virus Type 1 (HTLV-1) Antibody Assays in Cerebrospinal Fluid for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis. Journal of Clinical Microbiology. 59(5). 4 indexed citations
9.
Kodama, Daisuke, Masakazu Tanaka, Toshio Matsuzaki, et al.. (2020). Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. PLoS neglected tropical diseases. 14(7). e0008361–e0008361. 5 indexed citations
10.
Kawabata, Takashi, Ikkou Higashimoto, Hiroshi Takashima, Shuji Izumo, & Ryuji Kubota. (2012). Human T‐lymphotropic virus type I (HTLV‐I)‐specific CD8+ cells accumulate in the lungs of patients infected with HTLV‐I with pulmonary involvement. Journal of Medical Virology. 84(7). 1120–1127. 14 indexed citations
11.
12.
Sato, Tomoo, Natsumi Araya, Atae Utsunomiya, et al.. (2009). Severe loss of invariant NKT cells exhibiting anti–HTLV-1 activity in patients with HTLV-1–associated disorders. Blood. 114(15). 3208–3215. 43 indexed citations
13.
Xing, Hui, et al.. (2009). In vivo expression of proinflammatory cytokines in HIV encephalitis: an analysis of 11 autopsy cases. Neuropathology. 29(4). 433–442. 39 indexed citations
14.
Hayashi, Daisuke, Ryuji Kubota, Norihiro Takenouchi, et al.. (2008). Reduced Foxp3 expression with increased cytomegalovirus-specific CTL in HTLV-I-associated myelopathy. Journal of Neuroimmunology. 200(1-2). 115–124. 16 indexed citations
15.
Ito, Takashi, Koko Asakura, Tsuyoshi Fukuda, et al.. (2007). Regulation of Cytochrome P450 2E1 under Hypertonic Environment through TonEBP in Human Hepatocytes. Molecular Pharmacology. 72(1). 173–181. 21 indexed citations
16.
Kubota, Ryuji, Samantha S. Soldan, Roland Martinꝉ, & Steven Jacobson. (2002). Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient. Journal of NeuroVirology. 8(1). 53–57. 33 indexed citations
17.
18.
Kubota, Ryuji, Masahiro Nagai, Taketo Kawanishi, Mitsuhiro Osame, & Steven Jacobson. (2000). Increased HTLV Type 1 Tax Specific CD8 + Cells in HTLV Type 1-Asociated Myelopathy/Tropical Spastic Paraparesis: Correlation with HTLV Type 1 Proviral Load. AIDS Research and Human Retroviruses. 16(16). 1705–1709. 46 indexed citations
19.
Hashimoto, K., Jun–ichi Fujisawa, B.S. Singhal, et al.. (1993). Limited Sequence Divergence of HTLV-I of Indian HAM/TSP Patients from a Prototype Japanese Isolate. AIDS Research and Human Retroviruses. 9(6). 495–498. 21 indexed citations
20.
Kuriyama, M, et al.. (1992). Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients. Neuroradiology. 34(4). 308–312. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William Wachsman Breakdown of academic impact, for papers by Md. Zahidunnabi Dewan Breakdown of academic impact, for papers by Scott D. Blystone Breakdown of academic impact, for papers by Emma Terwilliger Breakdown of academic impact, for papers by E L Reinherz Breakdown of academic impact, for papers by Chung‐Yi Hu Breakdown of academic impact, for papers by Lucia Mincheva‐Nilsson Breakdown of academic impact, for papers by Robert L. Evans Breakdown of academic impact, for papers by Warren B. Nothnick Breakdown of academic impact, for papers by Hisashi Harada
Rankless by CCL
2026